APA (7th ed.) Citation

C, L., YT, C., Z, C., & Q, M. (2024). Nanoparticle-enhanced PD-1/PD-L1 targeted combination therapy for triple negative breast cancer. Frontiers in oncology, 14, 1393492. https://doi.org/10.3389/fonc.2024.1393492

Chicago Style (17th ed.) Citation

C, Linde, Chien YT, Chen Z, and Mu Q. "Nanoparticle-enhanced PD-1/PD-L1 Targeted Combination Therapy for Triple Negative Breast Cancer." Frontiers in Oncology 14 (2024): 1393492. https://doi.org/10.3389/fonc.2024.1393492.

MLA (9th ed.) Citation

C, Linde, et al. "Nanoparticle-enhanced PD-1/PD-L1 Targeted Combination Therapy for Triple Negative Breast Cancer." Frontiers in Oncology, vol. 14, 2024, p. 1393492, https://doi.org/10.3389/fonc.2024.1393492.